Trial reportBritish journal of sports medicine2026
Physiotherapist-led treatment for femoroacetabular impingement syndrome (the PhysioFIRST study): an assessor-blinded, limited disclosure randomised controlled trial.
Trial report in British journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveWe evaluated the effect of physiotherapist-led treatment with targeted-strengthening (STRENGTH) compared with physiotherapist-led treatment with standardised-stretching (STRETCH) on hip-related quality of life (QOL) and patient-perceived Global Rating of Change (GROC) at 6 months in people with femoroacetabular impingement (FAI) syndrome.
methodsAssessor-blind, limited disclosure, parallel, superiority randomised controlled trial. Participants aged 18-50 years with FAI syndrome were recruited and randomly allocated (1:1 ratio) to receive 6 months of STRENGTH or STRETCH treatment. Primary outcomes were change in (1) hip-related QOL (International Hip Outcome Tool-33 (iHOT-33, 0-100 points)); and (2) GROC-pain and GROC-function at 6 months. Secondary analysis included dichotomised GROC ('improved' and 'not improved') and hip muscle strength. Analyses were by intention to treat.
results154 participants (STRENGTH n=79 (53% women, mean 35 (SD 9) years); STRETCH n=75 (45% women, mean 36 (SD 9) years)) were included. There was no difference between groups for change in hip-related QOL (mean difference (95% CI) 0.2 (-5.9 to 6.3)) or patient-perceived global improvement (GROC-pain 0.2 (-0.2 to 0.7), p=0.23; GROC-function 0.3 (-0.1 to 0.6)) at 6 months. 72% of STRENGTH were improved for GROC-pain (OR 2.36 (1.15 to 4.84)) compared with 52% of STRETCH. STRENGTH had greater improvements than STRETCH in hip strength. Both groups improved in iHOT-33 over 6 months (STRENGTH 19.2 (15.7 to 22.8), STRETCH 20.8 (17.1 to 24.5) points).
conclusionThere was no superior physiotherapist-led treatment to improve hip-related QOL in people with FAI syndrome, but secondary analysis indicated that targeted strengthening resulted in greater improvements in perceived pain and hip muscle strength at 6 months. Hip-related QOL improved in both groups by clinically meaningful amounts. TRIAL REGISTRATION NUMBER: ACTRN12617001350314.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.